Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2022) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Current Neuropharmacology | journal | 1.168 Q1 | 103 | 156 | 307 | 20941 | 1976 | 293 | 5.03 | 134.24 |  |
| 2 | Mini-Reviews in Medicinal Chemistry | journal | 0.570 Q2 | 107 | 162 | 450 | 17321 | 1925 | 442 | 3.98 | 106.92 | |
| 3 | CNS and Neurological Disorders - Drug Targets | journal | 0.574 Q2 | 96 | 81 | 217 | 8156 | 639 | 205 | 2.86 | 100.69 | |
| 4 | Current Topics in Medicinal Chemistry | journal | 0.516 Q2 | 133 | 191 | 680 | 19008 | 1979 | 550 | 2.79 | 99.52 | |
| 5 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.558 Q2 | 52 | 35 | 97 | 3255 | 293 | 92 | 2.72 | 93.00 | |
| 6 | Current Nanomedicine | journal | 0.212 Q4 | 8 | 17 | 38 | 1475 | 37 | 37 | 0.97 | 86.76 | |
| 7 | Current Gene Therapy | journal | 0.564 Q3 | 80 | 36 | 122 | 3105 | 438 | 107 | 3.32 | 86.25 | |
| 8 | Current Stem Cell Research and Therapy | journal | 0.552 Q2 | 63 | 63 | 235 | 5371 | 704 | 221 | 2.36 | 85.25 | |
| 9 | Current Cancer Drug Targets | journal | 0.687 Q3 | 103 | 69 | 228 | 5875 | 726 | 219 | 2.97 | 85.14 | |
| 10 | Current Protein and Peptide Science | journal | 0.612 Q2 | 96 | 74 | 299 | 6244 | 966 | 277 | 2.58 | 84.38 | |
| 11 | Current Diabetes Reviews | journal | 0.696 Q2 | 68 | 93 | 280 | 7782 | 904 | 274 | 3.44 | 83.68 | |
| 12 | Recent Advances in Drug Delivery and Formulation | journal | 0.347 Q3 | 41 | 23 | 58 | 1876 | 145 | 52 | 1.80 | 81.57 | |
| 13 | Current Nanoscience | journal | 0.284 Q3 | 52 | 64 | 236 | 5132 | 387 | 228 | 1.65 | 80.19 | |
| 14 | Applications of NMR Spectroscopy | book series | 3 | 6 | 12 | 461 | 3 | 9 | 0.29 | 76.83 | | |
| 15 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.427 Q3 | 63 | 140 | 554 | 10373 | 1151 | 540 | 1.98 | 74.09 | |
| 16 | Current Alzheimer Research | journal | 0.637 Q2 | 103 | 84 | 336 | 6216 | 937 | 324 | 2.16 | 74.00 | |
| 17 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.280 Q3 | 27 | 18 | 87 | 1262 | 138 | 82 | 1.36 | 70.11 | |
| 18 | Current Cardiology Reviews | journal | 0.536 Q2 | 58 | 63 | 156 | 4269 | 404 | 146 | 1.78 | 67.76 | |
| 19 | Current Vascular Pharmacology | journal | 0.917 Q1 | 69 | 60 | 187 | 4056 | 722 | 153 | 3.99 | 67.60 | |
| 20 | Open Neuroimaging Journal | journal | 0.139 Q4 | 9 | 2 | 11 | 134 | 3 | 11 | 0.27 | 67.00 | |
| 21 | Current Nutrition and Food Science | journal | 0.223 Q4 | 32 | 87 | 358 | 5752 | 363 | 353 | 1.02 | 66.11 | |
| 22 | Current Aging Science | journal | 0.405 Q3 | 42 | 28 | 61 | 1823 | 136 | 59 | 1.96 | 65.11 | |
| 23 | Coronaviruses | journal | 7 | 48 | 183 | 3108 | 186 | 161 | 1.02 | 64.75 | | |
| 24 | Current Genomics | journal | 0.548 Q3 | 77 | 36 | 176 | 2328 | 481 | 153 | 2.55 | 64.67 | |
| 25 | Current Pediatric Reviews | journal | 0.701 Q2 | 33 | 35 | 105 | 2250 | 379 | 98 | 2.26 | 64.29 | |
| 26 | Current Chemical Biology | journal | 0.176 Q4 | 26 | 13 | 77 | 829 | 59 | 70 | 0.83 | 63.77 | |
| 27 | Current Hypertension Reviews | journal | 0.437 Q3 | 27 | 20 | 82 | 1274 | 204 | 72 | 2.14 | 63.70 | |
| 28 | Recent advances in inflammation & allergy drug discovery | journal | 0.973 Q1 | 37 | 15 | 44 | 896 | 252 | 39 | 2.59 | 59.73 | |
| 29 | Anti-Infective Agents | journal | 0.159 Q4 | 26 | 44 | 125 | 2557 | 94 | 120 | 0.69 | 58.11 | |
| 30 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.268 Q3 | 43 | 26 | 55 | 1492 | 98 | 49 | 1.37 | 57.38 | |
| 31 | Open Biomedical Engineering Journal | journal | 0.163 Q4 | 28 | 5 | 51 | 282 | 40 | 48 | 0.64 | 56.40 | |
| 32 | Current Drug Therapy | journal | 0.169 Q4 | 20 | 35 | 114 | 1963 | 79 | 111 | 0.70 | 56.09 | |
| 33 | Current Reviews in Clinical and Experimental Pharmacology | journal | 0.406 Q3 | 49 | 26 | 99 | 1407 | 188 | 94 | 1.72 | 54.12 | |
| 34 | Combinatorial Chemistry and High Throughput Screening | journal | 0.271 Q3 | 70 | 227 | 359 | 11817 | 560 | 333 | 1.65 | 52.06 | |
| 35 | Adolescent Psychiatry | journal | 5 | 19 | 70 | 984 | 25 | 59 | 0.36 | 51.79 | | |
| 36 | Current Cancer Therapy Reviews | journal | 0.147 Q4 | 17 | 37 | 88 | 1901 | 43 | 79 | 0.52 | 51.38 | |
| 37 | Infectious Disorders - Drug Targets | journal | 0.298 Q3 | 61 | 100 | 328 | 4928 | 482 | 311 | 1.40 | 49.28 | |
| 38 | Open Cardiovascular Medicine Journal | journal | 0.229 Q4 | 32 | 12 | 24 | 590 | 20 | 21 | 0.71 | 49.17 | |
| 39 | Clinical Practice and Epidemiology in Mental Health | journal | 0.906 Q2 | 58 | 24 | 90 | 1148 | 330 | 78 | 3.67 | 47.83 | |
| 40 | Current Computer-Aided Drug Design | journal | 0.258 Q3 | 32 | 42 | 195 | 1983 | 312 | 187 | 1.66 | 47.21 | |
| 41 | Open Anesthesia Journal | journal | 0.151 Q4 | 7 | 5 | 43 | 236 | 18 | 41 | 0.29 | 47.20 | |
| 42 | Current Radiopharmaceuticals | journal | 0.379 Q3 | 32 | 38 | 99 | 1789 | 195 | 87 | 1.75 | 47.08 | |
| 43 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.270 Q3 | 45 | 29 | 106 | 1316 | 124 | 100 | 1.09 | 45.38 | |
| 44 | Current Respiratory Medicine Reviews | journal | 0.117 Q4 | 15 | 43 | 117 | 1905 | 25 | 104 | 0.19 | 44.30 | |
| 45 | Current Rheumatology Reviews | journal | 0.381 Q3 | 29 | 49 | 151 | 2139 | 241 | 146 | 1.41 | 43.65 | |
| 46 | Open Biomarkers Journal | journal | 0.182 Q4 | 7 | 10 | 33 | 428 | 25 | 33 | 0.29 | 42.80 | |
| 47 | Reviews on Recent Clinical Trials | journal | 0.377 Q3 | 35 | 46 | 136 | 1902 | 226 | 119 | 1.60 | 41.35 | |
| 48 | Current Neurovascular Research | journal | 0.424 Q3 | 60 | 56 | 214 | 2297 | 394 | 199 | 2.00 | 41.02 | |
| 49 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.277 Q3 | 38 | 20 | 41 | 812 | 85 | 36 | 1.36 | 40.60 | |
| 50 | Current Signal Transduction Therapy | journal | 0.176 Q4 | 22 | 17 | 85 | 673 | 90 | 75 | 1.05 | 39.59 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data